Related Experiment Videos
A new fluorescent mitochondrial antibody: disease association
Irish Journal of Medical Science
|September 1, 1989
Summary
A rare M2(1) antibody, distinct from the M2 antimitochondrial antibody, presents an unusual immunofluorescent pattern. Its presence in patients with anemia or autoimmune diseases lacks specific diagnostic value, necessitating careful differentiation.
Area of Science:
- Immunology
- Autoimmunity
- Clinical Diagnostics
Background:
- An unusual immunofluorescent staining pattern was observed in patient sera.
- This pattern was associated with a novel antibody, designated M2(1).
- The M2(1) antibody differs from the M2 antimitochondrial antibody linked to primary biliary cirrhosis.
Purpose of the Study:
- To review cases with the M2(1) antibody.
- To characterize the clinical associations of the M2(1) antibody.
- To assess the diagnostic significance of the M2(1) antibody.
Main Methods:
- Retrospective review of case notes from 34 patients.
- Analysis of immunofluorescent staining patterns.
- Correlation of antibody presence with patient diagnoses.
Main Results:
- The M2(1) antibody exhibited a distinct staining pattern compared to the M2 antimitochondrial antibody.
- Associated conditions included anemia (10 patients), endocrine disease (7 patients), and autoimmune liver disease (6 patients).
- The M2(1) antibody did not demonstrate specific diagnostic significance.
Conclusions:
- The M2(1) antibody is rare and presents a unique immunofluorescent pattern.
- Clinical associations are varied and not specific.
- Distinguishing M2(1) from the M2 antimitochondrial antibody is crucial to avoid misdiagnosis in primary biliary cirrhosis.